Candriam S.C.A. Ascendis Pharma A/S Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Candriam S.C.A. holds 282,331 shares of ASND stock, worth $38.6 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

282,331

Previous 195,347 44.53%

Holding current value

$38.6 Million

Previous $26.6 Million 58.26%

% of portfolio

0.25%

Previous 0.16%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$113.0 - $153.43 $9.83 Million - $13.3 Million	86,984 Added 44.53%	282,331 $42.2 Million
Q2 2024 Aug 05, 2024	BUY	$121.07 - $153.67 $11.6 Million - $14.7 Million	95,972 Added 96.58%	195,347 $26.6 Million
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $3.44 Million - $5.09 Million	-40,000 Reduced 28.7%	99,375 $12.5 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $778,500 - $935,730	-9,000 Reduced 6.07%	139,375 $13.1 Million
Q2 2023 Aug 08, 2023	SELL	$69.96 - $97.84 $7.14 Million - $9.98 Million	-102,000 Reduced 40.74%	148,375 $13.2 Million
Q1 2023 May 12, 2023	BUY	$104.9 - $126.78 $6.29 Million - $7.61 Million	60,000 Added 31.52%	250,375 $26.8 Million
Q4 2022 Feb 13, 2023	SELL	$99.42 - $131.97 $1.59 Million - $2.11 Million	-16,000 Reduced 7.75%	190,375 $23.3 Million
Q3 2022 Nov 10, 2022	SELL	$84.03 - $110.23 $1.21 Million - $1.58 Million	-14,376 Reduced 6.51%	206,375 $21.3 Million
Q2 2022 Aug 03, 2022	BUY	$78.08 - $117.61 $4.41 Million - $6.64 Million	56,433 Added 34.34%	220,751 $20.5 Million
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $7.57 Million - $10.1 Million	-74,104 Reduced 31.08%	164,318 $19.3 Million
Q4 2021 Feb 10, 2022	SELL	$127.1 - $169.66 $1.52 Million - $2.03 Million	-11,977 Reduced 4.78%	238,422 $32.1 Million
Q3 2021 Nov 09, 2021	SELL	$112.67 - $176.92 $3.67 Million - $5.76 Million	-32,581 Reduced 11.51%	250,399 $39.9 Million
Q2 2021 Jul 20, 2021	BUY	$121.62 - $145.29 $5.15 Million - $6.15 Million	42,309 Added 17.58%	282,980 $37.2 Million
Q4 2020 Jan 22, 2021	SELL	$151.2 - $182.76 $4.3 Million - $5.19 Million	-28,408 Reduced 10.56%	240,671 $40.1 Million
Q3 2020 Oct 19, 2020	BUY	$134.29 - $154.32 $10.6 Million - $12.2 Million	79,000 Added 41.56%	269,079 $41.5 Million
Q2 2020 Jul 23, 2020	BUY	$110.87 - $156.01 $8.66 Million - $12.2 Million	78,079 Added 69.71%	190,079 $28.1 Million
Q4 2019 Jan 21, 2020	BUY	$91.45 - $139.12 $1.65 Million - $2.5 Million	18,000 Added 19.15%	112,000 $16,000
Q3 2019 Oct 21, 2019	BUY	$95.8 - $118.9 $9.01 Million - $11.2 Million	94,000 New	94,000 $9,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.62B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account